Fresenius Medical Care AG & Co. KGaAFMSNYSE
Loading
EBITDA Margin Over TimeStable
Percentile Rank0
3Y CAGR-5.1%
5Y CAGR-8.2%
Studio
Year-over-Year Change

EBITDA as a percentage of revenue

3Y CAGR
-5.1%/yr
vs +0.1%/yr prior
5Y CAGR
-8.2%/yr
Recent acceleration
Acceleration
-5.1pp
Decelerating
Percentile
P0
Near historical low
vs 5Y Ago
0.7x
Contraction
Streak
1 yr
Consecutive declineStable
PeriodValueYoY Change
202515.06%-9.1%
202416.58%+0.5%
202316.50%-6.4%
202217.62%-12.5%
202120.14%-12.9%
202023.14%+3.0%
201922.45%+27.7%
201817.58%+4.1%
201716.88%-5.4%
201617.84%-